Back to today’s briefing

Story perspectives

Study Links GLP-1 to Lower Glaucoma Risk in Diabetes

6/21/2025

31 2

Summary

Story summary

A recent study in Endocrinology, Diabetes & Metabolism explored the potential connection between GLP-1 receptor agonists and glaucoma risk in individuals with type 2 diabetes. While the findings suggested a slight decrease in glaucoma cases among GLP-1 users, the results were not significant. More research is essential to uncover how GLP-1 may protect eye health over time.

1 of 1

Story summary

A recent study in Endocrinology, Diabetes & Metabolism explored the potential connection between GLP-1 receptor agonists and glaucoma risk in individuals with type 2 diabetes. While the findings suggested a slight decrease in glaucoma cases among GLP-1 users, the results were not significant. More research is essential to uncover how GLP-1 may protect eye health over time.